Cancer Treatment News and Research

RSS

Genetic mutations involved in IGF-I signaling pathway influence life span

Mutations in genes governing an important cell-signaling pathway influence human longevity, scientists at the Albert Einstein College of Medicine of Yeshiva University have found.

6 Mar 2008

UK researchers look to improve treatment for lung cancer patients

Doctors from around the UK are taking part in one of the world's largest lung cancer clinical trials investigating how a blood thinning drug might help prevent blood clots in lung cancer patients.

5 Mar 2008

Experimental cancer drug MI-219 promising in preclinical studies

Researchers have long searched for a novel cancer drug that activates a certain protein to kill tumor cells.

4 Mar 2008

Protein in embryonic stem cells control malignant tumor cells

A protein that governs development of human embryonic stem cells (hESCs) also inhibits the growth and spread of malignant melanoma, the deadliest skin cancer, Northwestern University researchers have discovered.

4 Mar 2008

Colon cancer treatment, symptoms, clinical trials

Fewer people are dying from colorectal cancer, but it remains the third deadliest form of cancer in America.

4 Mar 2008

New global study of targeted therapies for breast cancer

Two targeted medications designed to treat an aggressive form of breast cancer are being tested in a new study involving 8,000 participants in 50 countries across six continents -- a clinical trial that investigators hope will provide a new model for global cancer research.

1 Mar 2008

Alarming confusion about cancer screening

Less than one in five people can name the three cancers screened for by the NHS screening programme - new figures reveal today.

28 Feb 2008

NIU seeks approval for new proton cancer treatment and research center

Northern Illinois University has named Northwestern Medical Faculty Foundation as its expected provider of clinical services for a new $160 million proton therapy cancer treatment and research center to be built in the DuPage National Technology Park about 35 miles west of Chicago.

27 Feb 2008

Enzyme Cdk1 may lead to new cancer therapies

With a four-year, $707,000 grant from the American Cancer Society, Yanchang Wang, assistant professor of biomedical sciences in the Florida State University College of Medicine, hopes to learn how a particular enzyme could possibly help put the brakes on the runaway cell division process that occurs in many forms of cancer.

27 Feb 2008

Small protein discovered that specifically recognizes tumors responding to chemotherapy

A technique that specifically "tags" tumors responding to chemotherapy may offer a new strategy for determining a cancer treatment's effectiveness within days of starting treatment, according to a new study by Vanderbilt-Ingram Cancer Center investigators.

26 Feb 2008

Smoking's effects on genes may play a role in lung cancer development and survival

Smoking plays a role in lung cancer development, and now scientists have shown that smoking also affects the way genes are expressed, leading to alterations in cell division and regulation of immune response.

21 Feb 2008

Maslinic acid from olives shows anti-cancer properties

A research group of the University of Granada has found out that maslinic acid, a compound present in the leaf and the olive skin wax extracted from alpeorujo (crushed olive pulp), has the capacity of preventing cancer as well as regulating apoptosis in carcinogenic processes.

14 Feb 2008

Avastin cancer drug does well in breast cancer study

A new study on the cancer drug Avastin has found that when the drug is combined with chemotherapy it slowed down the progression of breast cancer.

13 Feb 2008

Study finds widespread vitamin and mineral use among cancer survivors, although benefits of such use remain unclear

Use of vitamin and mineral supplements among cancer survivors is widespread, despite inconclusive evidence that such use is beneficial, according to a comprehensive review of scientific literature conducted by researchers at Fred Hutchinson Cancer Research Center and published Feb. 1 in the Journal of Clinical Oncology.

5 Feb 2008

Novel drug romiplostim significantly improves treatment of dangerous blood disorder

Two clinical trials of the novel drug romiplostim (Nplate) show that it significantly improved platelet levels in patients with chronic immune thrombocytopenic purpura (ITP), a hematologic disorder that can cause uncontrolled bleeding.

5 Feb 2008

Researchers examine immune cells where HIV can lie dormant, possible treatments

Researchers have determined how HIV is able to lie dormant in certain immune system cells and prevent the cells from self-destructing, according to a study published Thursday online in the journal Retrovirology, the AP/Google.com reports.

4 Feb 2008

Scientists identify protein's crucial role in resistance to breast cancer treatment

Scientists at the Breakthrough Breast Cancer Research Centre at The Institute of Cancer Research in London have identified how some breast cancers may become resistant to hormone treatments like tamoxifen.

4 Feb 2008

Event to address the effects of breast cancer on black women

Although the overall incidence of breast cancer in black women is lower than in white women, black women are more likely to die from breast cancer than their white counterparts.

4 Feb 2008

Researchers unravel mystery of cell division

Experts in mitosis (cell division) at the University of Virginia Health System have made discoveries that explain how one protein the kinase Aurora B could have such a large role in guiding and policing the process of cell division.

25 Jan 2008

M. D. Anderson, AstraZeneca form alliance to advance understanding of cancer-related pain

The University of Texas M. D. Anderson Cancer Center and AstraZeneca (NYSE:AZN) today announced that they will collaborate to help advance understanding of neuropathic pain caused by cancer chemotherapy, a side effect that often limits optimal therapeutic dosing in cancer treatments.

25 Jan 2008